Great profile on Fibrotech, Certa and OccuRx CEO Darren Kelly
by Uniseed01 | Nov 28, 2019 | Latest News
In conversation with Darren Kelly, CEO of Certa Therapeutics and OccuRx Uniseed Investee Companies by Amirah Al Idrus, Editor at FierceBiotech.Recent Posts
- CO2 conversion company LM Plus secures $600,000 seed funding led by Uniseed
- Uniseed Investee ENA Respiratory seeks participants for promising Australian COVID-19 preventative nasal spray – Sydney Phase I clinical trial
- Uniseed Completes 60th Start-Up Investment from Partner Research Organisations
- $10m invested into start-up developing new treatments targeting the use of CAR-T cell therapies against solid tumours
- Uniseed Investee ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Fund Raise
Archives
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- February 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- November 2017
- October 2017
- September 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- September 2016
- April 2016
- December 2015
- September 2015
- July 2015
- June 2015
- May 2015
- March 2015
- February 2015
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
Recent Comments